Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
A Phase 1 Study Evaluating Safety, Tolerability, and Preliminary Antitumor Activity of Entinostat and Nivolumab With or Without Ipilimumab in Advanced Solid Tumors
Sponsor: National Cancer Institute (NCI)
A PHASE1 clinical study on Anatomic Stage III Breast Cancer AJCC v8 and Anatomic Stage IV Breast Cancer AJCC v8, this trial is ongoing. The trial is conducted by National Cancer Institute (NCI) and has accumulated 45 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
45 versions recorded-
Nov 2025 — Present [monthly]
Active Not Recruiting PHASE1
-
Oct 2025 — Nov 2025 [monthly]
Active Not Recruiting PHASE1
-
May 2025 — Oct 2025 [monthly]
Active Not Recruiting PHASE1
-
Apr 2025 — May 2025 [monthly]
Active Not Recruiting PHASE1
-
Oct 2024 — Apr 2025 [monthly]
Active Not Recruiting PHASE1
▶ Show 40 earlier versions
-
Sep 2024 — Oct 2024 [monthly]
Active Not Recruiting PHASE1
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE1
-
Jul 2024 — Aug 2024 [monthly]
Active Not Recruiting PHASE1
-
Apr 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE1
-
Mar 2024 — Apr 2024 [monthly]
Active Not Recruiting PHASE1
-
Dec 2023 — Mar 2024 [monthly]
Active Not Recruiting PHASE1
-
Oct 2023 — Dec 2023 [monthly]
Active Not Recruiting PHASE1
-
Mar 2023 — Oct 2023 [monthly]
Active Not Recruiting PHASE1
-
Feb 2023 — Mar 2023 [monthly]
Active Not Recruiting PHASE1
-
Dec 2022 — Feb 2023 [monthly]
Active Not Recruiting PHASE1
-
Sep 2022 — Dec 2022 [monthly]
Active Not Recruiting PHASE1
-
Jul 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE1
-
May 2022 — Jul 2022 [monthly]
Active Not Recruiting PHASE1
-
Feb 2022 — May 2022 [monthly]
Active Not Recruiting PHASE1
-
Nov 2021 — Feb 2022 [monthly]
Active Not Recruiting PHASE1
-
Sep 2021 — Nov 2021 [monthly]
Active Not Recruiting PHASE1
-
May 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE1
-
Apr 2021 — May 2021 [monthly]
Active Not Recruiting PHASE1
-
Feb 2021 — Apr 2021 [monthly]
Active Not Recruiting PHASE1
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE1
-
Oct 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1
-
Jun 2020 — Oct 2020 [monthly]
Active Not Recruiting PHASE1
-
May 2020 — Jun 2020 [monthly]
Active Not Recruiting PHASE1
-
Apr 2020 — May 2020 [monthly]
Active Not Recruiting PHASE1
-
Feb 2020 — Apr 2020 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Jan 2020 — Feb 2020 [monthly]
Recruiting PHASE1
-
Nov 2019 — Jan 2020 [monthly]
Recruiting PHASE1
-
Sep 2019 — Nov 2019 [monthly]
Recruiting PHASE1
-
Aug 2019 — Sep 2019 [monthly]
Recruiting PHASE1
-
May 2019 — Aug 2019 [monthly]
Recruiting PHASE1
-
Apr 2019 — May 2019 [monthly]
Recruiting PHASE1
-
Mar 2019 — Apr 2019 [monthly]
Recruiting PHASE1
-
Dec 2018 — Mar 2019 [monthly]
Recruiting PHASE1
-
Jun 2018 — Dec 2018 [monthly]
Recruiting PHASE1
-
Dec 2017 — Jun 2018 [monthly]
Recruiting PHASE1
-
Nov 2017 — Dec 2017 [monthly]
Recruiting PHASE1
-
Jun 2017 — Nov 2017 [monthly]
Recruiting PHASE1
-
Apr 2017 — Jun 2017 [monthly]
Recruiting PHASE1
-
Feb 2017 — Apr 2017 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .